135 related articles for article (PubMed ID: 19480244)
21. Primary ovarian mucinous cystadenocarcinomas: a clinicopathologic study of 49 cases with long-term follow-up.
Hoerl HD; Hart WR
Am J Surg Pathol; 1998 Dec; 22(12):1449-62. PubMed ID: 9850171
[TBL] [Abstract][Full Text] [Related]
22. Relapse and disease specific survival in 1143 Danish women diagnosed with borderline ovarian tumours (BOT).
Karlsen NMS; Karlsen MA; Høgdall E; Nedergaard L; Christensen IJ; Høgdall C
Gynecol Oncol; 2016 Jul; 142(1):50-53. PubMed ID: 27168006
[TBL] [Abstract][Full Text] [Related]
23. Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas.
Rodríguez IM; Prat J
Am J Surg Pathol; 2002 Feb; 26(2):139-52. PubMed ID: 11812936
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants.
Kane A; Uzan C; Rey A; Gouy S; Camatte S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
Oncologist; 2009 Jun; 14(6):591-600. PubMed ID: 19487334
[TBL] [Abstract][Full Text] [Related]
25. Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors.
Moro F; Baima Poma C; Zannoni GF; Vidal Urbinati A; Pasciuto T; Ludovisi M; Moruzzi MC; Carinelli S; Franchi D; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2017 Dec; 50(6):788-799. PubMed ID: 28101917
[TBL] [Abstract][Full Text] [Related]
26. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients.
Zuna RE; Behrens A
J Natl Cancer Inst; 1996 Jul; 88(14):980-7. PubMed ID: 8667429
[TBL] [Abstract][Full Text] [Related]
27. Malignant and borderline epithelial ovarian tumors in the pediatric and adolescent population.
Nasioudis D; Alevizakos M; Holcomb K; Witkin SS
Maturitas; 2017 Feb; 96():45-50. PubMed ID: 28041594
[TBL] [Abstract][Full Text] [Related]
28. Borderline epithelial ovarian tumors: a review of 81 cases with an assessment of the impact of treatment.
Manchul LA; Simm J; Levin W; Fyles AW; Dembo AJ; Pringle JF; Rawlings GA; Sturgeon JF; Thomas GM
Int J Radiat Oncol Biol Phys; 1992; 22(5):867-74. PubMed ID: 1555978
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcome and risk factors for recurrence in borderline ovarian tumours.
Yokoyama Y; Moriya T; Takano T; Shoji T; Takahashi O; Nakahara K; Yamada H; Yaegashi N; Okamura K; Izutsu T; Sugiyama T; Tanaka T; Kurachi H; Sato A; Tase T; Mizunuma H
Br J Cancer; 2006 Jun; 94(11):1586-91. PubMed ID: 16685277
[TBL] [Abstract][Full Text] [Related]
30. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
Chen RF; Li J; Zhu TT; Yu HL; Lu X
J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
[TBL] [Abstract][Full Text] [Related]
31. Borderline epithelial ovarian tumors: a single center experience.
Numanoglu C; Ulker V; Kuru O; Akbayir O; Sakinci M; Akyol A
Eur J Gynaecol Oncol; 2014; 35(6):692-5. PubMed ID: 25556277
[TBL] [Abstract][Full Text] [Related]
32. Controversies in borderline ovarian tumors.
Seong SJ; Kim DH; Kim MK; Song T
J Gynecol Oncol; 2015 Oct; 26(4):343-9. PubMed ID: 26404125
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic factors and treatment for advanced-stage borderline ovarian tumors].
Morice P; Camatte S; Rouzier R; Pautier P; Atallah D; Pomel C; Lhomme C; Duvillard P; Castaigne D
J Gynecol Obstet Biol Reprod (Paris); 2002 Nov; 31(7):623-8. PubMed ID: 12457134
[TBL] [Abstract][Full Text] [Related]
34. [Risk factors for recurrent disease in borderline ovarian tumors].
Líbalová P; Vernerová Z; Hubicková-Heringová L; Pintérová D; Tikovský K; Kubecová M; Svoboda B
Ceska Gynekol; 2012 Feb; 77(1):31-5. PubMed ID: 22536638
[TBL] [Abstract][Full Text] [Related]
35. Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors.
Vancraeynest E; Moerman P; Leunen K; Amant F; Neven P; Vergote I
Int J Gynecol Cancer; 2016 Oct; 26(8):1399-406. PubMed ID: 27465897
[TBL] [Abstract][Full Text] [Related]
36. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004.
Wong HF; Low JJ; Chua Y; Busmanis I; Tay EH; Ho TH
Int J Gynecol Cancer; 2007; 17(2):342-9. PubMed ID: 17343573
[TBL] [Abstract][Full Text] [Related]
37. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
Kennedy AW; Hart WR
Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
[TBL] [Abstract][Full Text] [Related]
38. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
Anfinan N; Sait K; Ghatage P; Nation J; Chu P
Arch Gynecol Obstet; 2011 Sep; 284(3):731-5. PubMed ID: 20963432
[TBL] [Abstract][Full Text] [Related]
39. The Impact of Surgical Staging on the Prognosis of Mucinous Borderline Tumors of the Ovaries: A Multicenter Study.
Gungorduk K; Asicioglu O; Braicu EI; Almuheimid J; Gokulu SG; Cetinkaya N; Gungor T; Pakay G; Telli EU; Cuylan ZF; Toptas T; Bilgi A; Ozyurt R; Agacayak E; Ozdemir A; Yildirim N; Taskin S; Oge T; Erol O; Akman L; Turan A; Icen MS; Senol T; Ovali OI; Yucesoy B; Gungorduk O; Temizkan O; Sanci M; Simsek T; Meydanli MM; Harma M; Yasar L; Uysal AD; Karateke A; Ortac F; Ozalp SS; Sehouli J; Muallem MZ
Anticancer Res; 2017 Oct; 37(10):5609-5616. PubMed ID: 28982877
[TBL] [Abstract][Full Text] [Related]
40. Borderline ovarian tumors.
Link CJ; Reed E; Sarosy G; Kohn EC
Am J Med; 1996 Aug; 101(2):217-25. PubMed ID: 8757363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
